A Doctor's prescription for play: could exercise be the medicine for childhood obesity?

NCT ID NCT04847271

NEW Completed Disease control Sponsor: Vastra Gotaland Region Source: ClinicalTrials.gov ↗

First seen Aug 19, 2026 · Last updated Aug 19, 2026

Summary

This trial tests whether a 'physical activity on prescription' (PAP) program can help children aged 6-12 with obesity become more active. Over 4 months, children choose activities they enjoy and follow a written prescription for how often and how long to do them. Researchers will measure changes in physical activity, BMI, waist size, and quality of life, and also see how well the program fits into pediatric care. The goal is to find out if this approach is practical and beneficial for kids.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Physical activity on prescription (PAP) — a structured program where children choose physical activities to do for 4 months
What this could lead to: If this works, it could offer a practical, personalized way to help children with obesity become more active and improve their health.
What could go wrong: This is a small feasibility study, so results may not apply broadly. Children may not stick with the prescribed activities, and the program's success depends on healthcare clinics adopting it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity obesity disorder Pediatric Obesity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY, CHILDHOOD

Contacts and locations

Locations

Regionhälsan, Region Västra Götaland

Gothenburg, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.